Kirsten AM and Förster K and Radeczky E and Linnhoff A and Bálint Beatrix and Watz H and Wray H and Salkeld L and Cullberg M and Larsson B:
The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPD.
PULMONARY PHARMACOLOGY & THERAPEUTICS, 31.
pp. 36-41.
ISSN 1094-5539
(2015)